ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
NCT: NCT07568015 · NOT_YET_RECRUITING
Brief Summary
The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.
Frequently Asked Questions
What is ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain?
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain is a clinical trial registered under NCT07568015. Current status: NOT_YET_RECRUITING.
What is the status of NCT07568015?
The current status of NCT07568015 (ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain) is: NOT_YET_RECRUITING.
When did ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain start?
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain started on 2026-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.